Literature DB >> 35706970

Analysis of interval-censored competing risks data under missing causes.

Debanjan Mitra1, Ujjwal Das1, Kalyan Das2.   

Abstract

In this article, interval-censored competing risks data are analyzed when some of the causes of failure are missing. The vertical modeling approach has been proposed here. This approach utilizes the data to extract information to the maximum possible extent especially when some causes of failure are missing. The maximum likelihood estimates of the model parameters are obtained. The asymptotic confidence intervals for the model parameters are constructed using approaches based on observed Fisher information matrix, and parametric bootstrap. A simulation study is considered in detail to assess the performance of the point and interval estimators. It is observed that the proposed analysis performs better than the complete case analysis. This establishes the fact that the our methodology is an extremely useful technique for interval-censored competing risks data when some of the causes of failure are missing. Such analysis seems to be quite useful for smaller sample sizes where complete case analysis may have a significant impact on the inferential procedures. Through Monte Carlo simulations, the effect of a possible model misspecification is also assessed on the basis of the cumulative incidence function. For illustration purposes, three datasets are analyzed and in all cases the conclusion appears to be quite realistic.
© 2019 Informa UK Limited, trading as Taylor & Francis Group.

Entities:  

Keywords:  Gompertz model; Interval censoring; competing risks; confidence intervals; cumulative incidence function; maximum likelihood estimates

Year:  2019        PMID: 35706970      PMCID: PMC9097972          DOI: 10.1080/02664763.2019.1642309

Source DB:  PubMed          Journal:  J Appl Stat        ISSN: 0266-4763            Impact factor:   1.416


  18 in total

1.  Multiple imputation methods for estimating regression coefficients in the competing risks model with missing cause of failure.

Authors:  K Lu; A A Tsiatis
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

2.  Vertical modelling: Analysis of competing risks data with missing causes of failure.

Authors:  M A Nicolaie; H C van Houwelingen; H Putter
Journal:  Stat Methods Med Res       Date:  2011-12-16       Impact factor: 3.021

3.  Modelling competing risks data with missing cause of failure.

Authors:  Giorgos Bakoyannis; Fotios Siannis; Giota Touloumi
Journal:  Stat Med       Date:  2010-12-30       Impact factor: 2.373

4.  Inference for the dependent competing risks model with masked causes of failure.

Authors:  Radu V Craiu; Benjamin Reiser
Journal:  Lifetime Data Anal       Date:  2006-03       Impact factor: 1.588

5.  Vertical modeling: a pattern mixture approach for competing risks modeling.

Authors:  M A Nicolaie; Hans C van Houwelingen; H Putter
Journal:  Stat Med       Date:  2010-05-20       Impact factor: 2.373

6.  Parametric likelihood inference for interval censored competing risks data.

Authors:  Michael G Hudgens; Chenxi Li; Jason P Fine
Journal:  Biometrics       Date:  2014-01-08       Impact factor: 2.571

Review 7.  A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions.

Authors:  Aurelien Latouche; Arthur Allignol; Jan Beyersmann; Myriam Labopin; Jason P Fine
Journal:  J Clin Epidemiol       Date:  2013-02-14       Impact factor: 6.437

8.  Semiparametric regression on cumulative incidence function with interval-censored competing risks data.

Authors:  Giorgos Bakoyannis; Menggang Yu; Constantin T Yiannoutsos
Journal:  Stat Med       Date:  2017-06-12       Impact factor: 2.373

9.  A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew F Plevak; L Joseph Melton
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

10.  Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2.

Authors:  E A Copelan; J C Biggs; J M Thompson; P Crilley; J Szer; J P Klein; N Kapoor; B R Avalos; I Cunningham; K Atkinson
Journal:  Blood       Date:  1991-08-01       Impact factor: 22.113

View more
  1 in total

1.  Semiparametric regression on cumulative incidence function with interval-censored competing risks data and missing event types.

Authors:  Jun Park; Giorgos Bakoyannis; Ying Zhang; Constantin T Yiannoutsos
Journal:  Biostatistics       Date:  2022-07-18       Impact factor: 5.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.